1. Home
  2. BEEM vs BCTX Comparison

BEEM vs BCTX Comparison

Compare BEEM & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

HOLD

Current Price

$1.15

Market Cap

28.6M

Sector

Technology

ML Signal

HOLD

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$3.42

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEM
BCTX
Founded
2006
2014
Country
United States
Canada
Employees
220
4
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
26.6M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
BEEM
BCTX
Price
$1.15
$3.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$3.50
$40.00
AVG Volume (30 Days)
395.2K
102.1K
Earning Date
04-09-2026
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$40.48
N/A
Revenue Next Year
$32.17
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.97
$0.63
52 Week High
$4.04
$14.68

Technical Indicators

Market Signals
Indicator
BEEM
BCTX
Relative Strength Index (RSI) 52.04 47.10
Support Level $1.13 $3.27
Resistance Level $1.66 $4.51
Average True Range (ATR) 0.06 0.25
MACD 0.02 -0.02
Stochastic Oscillator 88.08 26.73

Price Performance

Historical Comparison
BEEM
BCTX

About BEEM Beam Global

Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: